• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Senseonics Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    5/8/25 4:09:18 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials
    Get the next $SENS alert in real time by email
    0001616543false00016165432025-05-082025-05-08

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d) OF THE

    SECURITIES EXCHANGE ACT OF 1934

    Date of Report (Date of earliest event reported): May 8, 2025

    ​

    SENSEONICS HOLDINGS, INC.

    (Exact Name of Registrant as Specified in its Charter)

    ​

    ​

    ​

    ​

    ​

    ​

    Delaware

    ​

    001-37717

    ​

    47-1210911

    (State or Other
    Jurisdiction of Incorporation)

    ​

    (Commission File Number)

    ​

    (IRS Employer
    Identification No.)

    ​

    ​

    20451 Seneca Meadows Parkway
    Germantown, MD 20876-7005

    (Address of Principal Executive Office) (Zip Code)

    ​

    Registrant's telephone number, including area code: (301) 515-7260

    Not Applicable

    Former name or former address, if changed since last report

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class

    Trading Symbol(s)

    Name of each exchange on which registered

    Common Stock

    SENS

    NYSE American

    ​

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    ​

    Emerging growth company ☐

    ​

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    ​

    ​

    Item 2.02. Results of Operations and Financial Condition.

     

    On May 8, 2025, Senseonics Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2025, as well as information regarding a conference call to discuss these financial results and the Company’s recent corporate highlights and outlook. This press release has been furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by this reference.    

    The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

    Item 9.01. Financial Statements and Exhibits.

    ​

    (d) Exhibits.

     

    Exhibit

    ​

    ​

    Number

     

    Description

     

     

     

    99.1

     

    Press Release of Senseonics Holdings, Inc. dated May 8, 2025.

    ​

    ​

    104

     

    Cover Page Interactive Data (embedded within the Inline XBRL document).

    ​

    ​

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ay

    ​

    ​

    Date: May 8, 2025

    SENSEONICS HOLDINGS, INC.

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    By:

    /s/ Rick Sullivan

    ​

    Name:

    Rick Sullivan

    ​

    Title:

    Chief Financial Officer

    ​

    ​

    ​

    ​

    ​

    Get the next $SENS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SENS

    DatePrice TargetRatingAnalyst
    4/10/2025$2.00Outperform
    Mizuho
    7/19/2023$0.50Underperform
    Jefferies
    8/19/2021$6.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $SENS
    Financials

    Live finance-specific insights

    See more
    • Senseonics Holdings, Inc. Reports First Quarter Financial Results

      Q1 Revenue of $6.3 million, growth year over year of 24% Partnership with Sequel integrates twiist™ automated insulin delivery (AID) system with Eversense® 365 one-year continuous glucose monitor (CGM); twiist with Eversense 365 launch expected in Q3 GERMANTOWN, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights & Accomplishments: Generated revenue of $6.3 million in the first quarter of 2025CMS upda

      5/8/25 4:05:00 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time

      GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its first quarter 2025 financial results after market close on Thursday, May 8, 2025. Management will hold a conference call to review the Company's first quarter 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigat

      4/29/25 4:05:00 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

      Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia Patient base increased 56% in 2024 over 2023 to approximately 6,000 global patients GERMANTOWN, Md., March 03, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the fourth quarter ended December 31, 2024. Recent Highlights & Accomplishments: Eversense® 365 approved and launched in the U.S. during 2024 as an integrated contin

      3/3/25 4:05:00 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    SEC Filings

    See more
    • Senseonics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Senseonics Holdings, Inc. (0001616543) (Filer)

      5/16/25 5:20:57 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • SEC Form 424B5 filed by Senseonics Holdings Inc.

      424B5 - Senseonics Holdings, Inc. (0001616543) (Filer)

      5/16/25 4:22:32 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • SEC Form 424B5 filed by Senseonics Holdings Inc.

      424B5 - Senseonics Holdings, Inc. (0001616543) (Filer)

      5/15/25 5:20:36 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

      GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the pricing of an underwritten public offering of 100,000,000 shares of common stock at a price to the public of $0.50 per share of common stock. The gross proceeds to Senseonics from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be $50,000,000. In addition, Senseonics granted the underwriters a 30-day option to purchase up to an additional 15,000,

      5/15/25 11:12:42 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement

      GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell shares of its common stock. In connection with the proposed offering, Senseonics also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the total number of shares of common stock offered in the public offering. All of the shares of common stock to be sold in the proposed

      5/15/25 4:05:39 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Senseonics Holdings, Inc. Reports First Quarter Financial Results

      Q1 Revenue of $6.3 million, growth year over year of 24% Partnership with Sequel integrates twiist™ automated insulin delivery (AID) system with Eversense® 365 one-year continuous glucose monitor (CGM); twiist with Eversense 365 launch expected in Q3 GERMANTOWN, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights & Accomplishments: Generated revenue of $6.3 million in the first quarter of 2025CMS upda

      5/8/25 4:05:00 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Director Roeder Douglas A bought $37,500 worth of shares (75,000 units at $0.50), increasing direct ownership by 5% to 1,463,087 units (SEC Form 4)

      4/A - Senseonics Holdings, Inc. (0001616543) (Issuer)

      12/20/24 5:37:53 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Director Roeder Douglas A bought $135,500 worth of shares (325,000 units at $0.42), increasing direct ownership by 30% to 1,413,087 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      12/16/24 4:21:25 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Chief Financial Officer Sullivan Frederick T. bought $47,475 worth of shares (124,933 units at $0.38), increasing direct ownership by 5% to 2,478,844 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      12/12/24 7:04:14 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Mizuho initiated coverage on Senseonics with a new price target

      Mizuho initiated coverage of Senseonics with a rating of Outperform and set a new price target of $2.00

      4/10/25 12:43:40 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Jefferies initiated coverage on Senseonics with a new price target

      Jefferies initiated coverage of Senseonics with a rating of Underperform and set a new price target of $0.50

      7/19/23 7:24:20 AM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • HC Wainwright & Co. initiated coverage on Senseonics Holdings with a new price target

      HC Wainwright & Co. initiated coverage of Senseonics Holdings with a rating of Buy and set a new price target of $6.00

      8/19/21 6:19:58 AM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Fiorentino Edward was granted 21,243 shares, increasing direct ownership by 2% to 1,204,041 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      4/3/25 4:30:45 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Director Steven Edelman was granted 19,363 shares, increasing direct ownership by 2% to 1,124,567 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      4/3/25 4:30:38 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Director Prince Douglas S was granted 12,219 shares, increasing direct ownership by 1% to 959,152 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      4/3/25 4:30:38 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

      SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

      2/13/24 5:13:59 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

      SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

      7/7/23 4:35:55 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G filed by Senseonics Holdings Inc.

      SC 13G - Senseonics Holdings, Inc. (0001616543) (Subject)

      4/10/23 5:10:45 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials